Dova Pharmaceuticals Reports Third Quarter 2017 Operating and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Dova Pharmaceuticals (DOVA) Misses Q3 EPS by 6c
November 9, 2017 4:14 PM ESTDova Pharmaceuticals (NASDAQ: DOVA) reported Q3 EPS of ($0.38), $0.06 worse than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Dova Pharmaceuticals (DOVA) click here.
... More